Repare is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells.
Repare Therapeutics, Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.reparerx.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address7210 Frederick-Banting, Suite 100, Quebec, H4S 2A1St-LaurentUnited States
7210 Frederick-Banting, Suite 100, Quebec, H4S 2A1
St-Laurent
United States
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/repare-therapeutics” connections=”true” suffix=””]
In Jan 2019, Repare Therapeutics, Inc. Enters into Strategic Partnership Agreement With ONO Pharmaceutical Co., Ltd. for Repare’s Polθ Inhibitor Program. Under the terms of the agreement, ONO will provide an up-front payment and research service payments potentially totaling US $15M, plus additional cost-sharing through IND..